Facing $50B Trial, Drugmakers Minimize Roles In Opioid Sales
Emily Field and Jeff Overley, 20 April 2021
Allergan PLC on Tuesday downplayed its Golden State opioid sales, echoing the strategies of fellow drugmaker defendants from the day before in a closely watched trial where major California counties are seeking $50 billion over the addiction epidemic.
Donna Welch of Kirkland & Ellis LLP, counsel for Allergan, said during the livestreamed bench trial that the company was responsible for one brand-name opioid, Kadian, from 2009 until it was taken off the market in 2020, and that its market share during that time was minuscule — less than a fraction of 1%.
In addition, Allergan stopped marketing the drug in 2012, and even before then, the marketing was conservative and had little if any impact on sales, Welch said. Continue reading “Article: Facing $50B Trial, Drugmakers Minimize Roles In Opioid Sales”

As The Block reported last week, Gary Gensler is now chairman of the U.S. Securities and Exchange Commission after being sworn into office.
Financial industry pioneer Richard Sandor is ramping up his efforts to compete in the race to replace the London interbank offered rate, which helps set borrowing costs on everything from mortgages to business loans.
Apparently, firing half a dozen executives including its head of risk management (Lara Warner, also one of the most high-ranking women in the global financial services industry) hasn’t done enough to quiet shareholders’ demands for change atop Credit Suisse, the Swiss banking giant that reported a $4.7 billion loss from the collapse of Archegos Capital Management, with billions of losses likely to follow from the collapse for Greensill.
A fatal crash in Texas involving a Tesla vehicle purportedly in semi-autonomous mode with no driver behind the wheel has sparked dual federal investigations that will invite sharper regulatory scrutiny of potential gaps in self-driving car technology, even as CEO Elon Musk flatly rejects suggestions that Autopilot was a factor.
A Boston federal judge on Monday laid out plans for the district’s first high-profile criminal jury trial since the start of the COVID-19 pandemic, walking attorneys through an exhaustive set of safety measures including witness stands encased in plexiglass and disposable microphone covers.